General Practice · New York, NY
NPI
1790714962
Since 2006
Specialty
General Practice
Code 208D00000X
Group practices
3
Medicare group memberships
Hospitals
0
Hospital affiliations
435 Fort Washington Ave, Suite 1c
New York, NY, 10033
Phone (212) 923-0408
Groups this clinician bills Medicare through
Medicare paid, 2024
$20K
478 services
Medicare patients, 2024
91
Average age 75
Drug cost, 2024
$5.0M
26,629 prescriptions
Company payments, 2025
$3,639
From 27 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jose A Goris was code 99213 (office e&m - established), 93 times for 50 patients. In total Jose A Goris billed 478 services in 26 codes, and Medicare paid $20K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-03-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 93 | 50 | $74.15 | $6,896 |
| 36415 Venipuncture Blood Collection | Office | 82 | 65 | $8.65 | $709 |
| 99212 Office E&M - Established | Office | 73 | 51 | $43.74 | $3,193 |
| 82947 Clinical Chemistry | Office | 60 | 35 | $3.85 | $231 |
| 93000 Electrocardiogram | Office | 36 | 36 | $12.13 | $437 |
| 96127 Behavioral Health Services | Office | 32 | 23 | $4.11 | $132 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 20 | 20 | $142.67 | $2,853 |
| 99214 Office E&M - Established | Office | 17 | 16 | $112.40 | $1,911 |
| 90658 Vaccine Product | Office | 11 | 11 | $21.42 | $236 |
By year: 2022 $57K for 1,350 services; 2023 $41K for 925 services; 2024 $20K for 478 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 82 | 65 | $8.65 | $709 |
| 82947 Clinical Chemistry | 60 | 35 | $3.85 | $231 |
Medicare prescription drug claims, 2024
In 2024, the drug Jose A Goris prescribed most often to Medicare patients was Atorvastatin Calcium, with 1,512 prescriptions and refills. In total Jose A Goris wrote 26,629 Medicare prescriptions that cost $5.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 1,512 | 4,171 | 587 | $19K |
| Amlodipine Besylate Generic | 1,053 | 2,832 | 398 | $6,153 |
| Omeprazole Generic | 1,039 | 1,793 | 312 | $8,176 |
| Gabapentin Generic | 689 | 1,425 | 255 | $5,706 |
| Metformin Hcl Generic | 676 | 1,850 | 270 | $3,472 |
| Losartan Potassium Generic | 568 | 1,523 | 228 | $5,880 |
| Rosuvastatin Calcium Generic | 558 | 1,539 | 224 | $7,808 |
| Diclofenac Sodium Generic | 498 | 615 | 204 | $14K |
| Metoprolol Succinate Generic | 491 | 1,318 | 183 | $8,436 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 478 | 979 | 173 | $29K |
| Pantoprazole Sodium Generic | 454 | 851 | 151 | $3,370 |
| Losartan-Hydrochlorothiazide Losartan/Hydrochlorothiazide | 430 | 1,142 | 165 | $13K |
| Tamsulosin Hcl Generic | 406 | 1,118 | 167 | $5,946 |
| Hydrochlorothiazide Generic | 376 | 1,030 | 156 | $803 |
| Jardiance Empagliflozin | 366 | 656 | 100 | $369K |
Brand drugs: 5,704 claims; generic drugs: 20,064 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jose A Goris $3,639 ($3,639 in general payments such as food, travel and fees) from 27 companies. The largest payer was Intra-Sana Laboratories with $473.
| Company | Payments | Amount |
|---|---|---|
| Intra-Sana Laboratories | 9 | $473 |
| Xeris Pharmaceuticals, Inc. | 5 | $446 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 13 | $381 |
| AstraZeneca Pharmaceuticals LP AZN | 8 | $264 |
| Novo Nordisk Inc NVO | 7 | $203 |
| Abbvie Inc. ABBV | 16 | $187 |
| Insulet Corporation PODD | 1 | $165 |
| Pfizer Inc. PFE | 8 | $157 |
| Phathom Pharmaceuticals, Inc. PHAT | 2 | $156 |
| GlaxoSmithKline, LLC. GSK | 6 | $138 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.